Home › Funds › Opaleye Management Inc. › VYGR

Opaleye Management Inc. position in VYGR

VOYAGER THERAPEUTICS INC · Health Care

Opaleye Management Inc. reported holding 1,185,000 shares of VYGR (VOYAGER THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$4.1M, representing 0.38% of its reported portfolio and ranking #39 among its reported holdings. Opaleye Management Inc. has disclosed VYGR holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)1.19M sh
Reported value held$4.15M
Portfolio Weight0.38%
First reportedQ4 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Opaleye Management Inc.'s VYGR position evolved

Opaleye Management Inc. first disclosed a stake in VYGR in Q4 2025 at 1,196,904 shares (US$4.7M). Across 3 filings, Opaleye Management Inc. increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,185,000 shares valued at US$4.1M — an increase of 35,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 1.20M $4.70M New
Q1 2026 1.15M $4.44M Reduce
Q2 2026 1.19M $4.15M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VYGR and 13F data

VYGR (VOYAGER THERAPEUTICS INC) is a Health Care company. 17 other funds we track also report a position in VYGR. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VYGR

No other tracked fund reports a position in VYGR.

All VYGR fund holders →

FAQ

How long has Opaleye Management Inc. held VYGR?

Opaleye Management Inc. has disclosed VYGR holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Opaleye Management Inc.'s current position in VYGR?

As of Q2 2026, Opaleye Management Inc. holds 1.19M shares of VYGR (VOYAGER THERAPEUTICS INC), valued at $4.15M, representing 0.38% of its reported portfolio and ranking #39.

Has Opaleye Management Inc. been buying or selling VYGR?

In the latest 13F filing (Q2 2026), Opaleye Management Inc. increased its position in VYGR.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.